Markers of bone turnover for monitoring treatment of osteoporosis with antiresorptive drugs.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA ·Vol. 11 Suppl 6 ·2000-00-00 ·Pages S66-76

Delmas PD

Abstract

暂无摘要

MeSH Terms

Biomarkers/blood,urine Bone Density/physiology Bone Remodeling/drug effects Diphosphonates/administration & dosage Estradiol/administration & dosage Estrogen Replacement Therapy Female Humans Osteoporosis, Postmenopausal/diagnosis,drug therapy Raloxifene Hydrochloride/administration & dosage Treatment Outcome

Chemicals

Biomarkers Diphosphonates Raloxifene Hydrochloride Estradiol

Authors & Affiliations

1 authors, click to expand affiliations / ORCID

Delmas P D

Inserm Research Unit 403 and Claude Bernard University of Lyon, France. delmas@lyon151.inserm.fr

Article Info

Journal

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Abbr.

Osteoporos Int

ISSN

0937-941X

DOI

10.1007/s001980070007

delmas@lyon151.inserm.fr

Published

2000-00-00

Pages

S66-76

Language